P44/42 MAPK (ERK1/2) Monoclonal Antibody(6B1)

The protein encoded by this gene is a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act in a signaling cascade that regulates various cellular processes such as proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals. This kinase is activated by upstream kinases, resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Alternatively spliced transcript variants encoding different protein isoforms have been described.

The P44/42 MAPK (ERK1/2) Monoclonal Antibody (6B1) is a highly specific and reliable tool for the detection and analysis of the P44/42 mitogen-activated protein kinase (MAPK) pathway. This monoclonal antibody is designed to target and bind to the extracellular signal-regulated kinases 1 and 2 (ERK1/2), which play a crucial role in cellular signaling and regulation of various biological processes.

With its exceptional specificity, the P44/42 MAPK (ERK1/2) Monoclonal Antibody (6B1) ensures accurate and precise detection of ERK1/2 proteins in a wide range of samples, including cell lysates, tissue extracts, and immunohistochemistry applications. Its high affinity and sensitivity enable researchers to obtain reliable and reproducible results, making it an indispensable tool for studying the intricate mechanisms of the MAPK signaling pathway.

This monoclonal antibody is produced using advanced techniques and undergoes rigorous quality control measures to ensure its purity, consistency, and functionality. It is supplied as a liquid formulation, ready for immediate use, eliminating the need for time-consuming reconstitution procedures.

The P44/42 MAPK (ERK1/2) Monoclonal Antibody (6B1) is compatible with various experimental techniques, including Western blotting, immunoprecipitation, and immunofluorescence, allowing for versatile applications in diverse research fields such as cancer biology, developmental biology, and signal transduction studies.

Choose the P44/42 MAPK (ERK1/2) Monoclonal Antibody (6B1) for its exceptional performance, reliability, and specificity, and unlock new insights into the intricate workings of the P44/42 MAPK pathway.